Vitiligo Treatment

Vitiligo treatment aims to slow active pigment loss, encourage repigmentation and make living with colour change easier. Vitiligo is an immune-mediated condition in which melanocytes are damaged; it is not contagious, caused by poor hygiene or something a person has eaten. Treatment is optional, and choosing camouflage or no medical treatment is valid.

Vitiligo Treatment

Vitiligo treatment aims to slow active pigment loss, encourage repigmentation and make living with colour change easier. Vitiligo is an immune-mediated condition in which melanocytes are damaged; it is not contagious, caused by poor hygiene or something a person has eaten. Treatment is optional, and choosing camouflage or no medical treatment is valid.

White patches are not automatically vitiligo. Fungal infection, post-inflammatory colour loss, chemical exposure and several inflammatory or genetic conditions can look similar. A dermatologist may examine the distribution, use a Wood's lamp and occasionally request blood tests or a biopsy when the diagnosis is uncertain. The plan then depends on whether disease is active, segmental or non-segmental, localised or extensive.

What Is Vitiligo Treatment?

Vitiligo treatment aims to stop new depigmented patches from developing and restore colour where possible, but it does not currently cure the autoimmune condition. A dermatologist confirms the diagnosis, pattern and activity and may check for associated autoimmune disease. Options include a limited course of topical corticosteroid, tacrolimus or pimecrolimus, ruxolitinib for suitable non-segmental vitiligo, narrowband UVB phototherapy, targeted excimer treatment or surgery for carefully selected stable disease. Response is gradual and varies by site; face and neck often respond better than fingertips or toes. Sun protection, camouflage and psychological support are valid parts of care, and maintenance may be needed.

Clinical patternTypical priorityImportant limitation
New or rapidly spreading patchesControl disease activityRepigmentation treatment alone may not stop spread
Localised non-segmental vitiligoTopical therapy or targeted lightResponse differs by body site
Widespread non-segmental vitiligoNarrowband UVB phototherapyRequires repeated supervised visits
Stable segmental patchSelected surgical or cellular procedureNot suitable while disease is changing
Hands, feet or white hair within a patchRealistic counselling and camouflageFollicular pigment reserve may be limited

Indicative Treatment Price Guide

Prices are indicative Delhi NCR estimates and may vary by diagnosis, treatment area, product, medicine, device, clinician, session plan and clinic. Confirm medical suitability and a written quote before treatment.

SNo.Treatment NamePrice RangeCity
1Vitiligo consultation and Wood-lamp examโ‚น500โ€“โ‚น2,000 per visitDelhi NCR
2Prescription topical treatmentโ‚น800โ€“โ‚น4,000 per monthDelhi NCR
3Narrowband UVB phototherapyโ‚น500โ€“โ‚น1,500 per sessionDelhi NCR
4Targeted excimer treatmentโ‚น1,500โ€“โ‚น4,000 per sessionDelhi NCR

What a realistic result looks like

Repigmentation commonly begins as small brown dots around hair follicles or colour moving inward from patch borders. The face and neck often respond better than fingertips, toes and bony areas. Results take months, and stopping successful therapy can be followed by colour loss. No responsible clinician can promise a permanent cure or an identical response on every patch.

Standardised photographs are more useful than daily mirror checks. They show whether borders have stopped expanding, new patches have appeared and repigmentation is durable after temporary redness settles.

Topical vitiligo treatment

Vitiligo creams are most practical for limited areas. A topical corticosteroid can reduce local immune activity, but strength, site and duration must be prescribed carefully because prolonged misuse may thin skin, cause stretch marks or affect small vessels. Eyelids and skin folds need particular caution.

Topical calcineurin inhibitors such as tacrolimus or pimecrolimus are steroid-sparing options often considered for the face or folds. Temporary warmth or stinging may occur. Topical ruxolitinib, a JAK inhibitor, is an approved option in the United States for eligible adults and adolescents aged 12 years or older with non-segmental vitiligo affecting a limited body surface area. Eligibility, medicine interactions, warnings and local approval must be reviewed by the prescriber.

Phototherapy and excimer treatment

Narrowband UVB phototherapy for vitiligo exposes skin to a measured ultraviolet wavelength in a medical unit. It may suit widespread disease and is usually delivered repeatedly over many months. Dose is adjusted to skin response; uncontrolled tanning or a home lamp without prescription is not equivalent.

Excimer laser for vitiligo directs targeted UVB-range light to limited patches while sparing unaffected skin. It can be useful for localised areas but is time-consuming for extensive disease. Redness, burning, blistering or darker borders can occur with light-based treatment. Eye protection and cumulative exposure records matter.

Comparing common vitiligo options

OptionOften considered forPractical point
Topical corticosteroidLimited body patchesNeeds site-specific duration monitoring
Calcineurin inhibitorFace and foldsSteroid-sparing; may sting initially
Topical ruxolitinibEligible non-segmental vitiligoResponse may require more than 24 weeks
Narrowband UVBWidespread or active diseaseFrequent visits and gradual response
Excimer laserSelected localised patchesTargeted but impractical for large areas
Grafting or cell transferCarefully selected stable diseaseCan scar or create uneven colour

Surgery for stable vitiligo

Vitiligo surgery may transfer small grafts, epidermal tissue or melanocyte-containing cells into stable, treatment-resistant patches. Stability is essential: operating while new patches are appearing can lead to failure or new depigmentation at injury sites through the Koebner phenomenon. Infection, scarring, cobblestoning, colour mismatch and incomplete fill are possible.

Surgery is not a shortcut for widespread active disease. The clinician should document how stability was judged, which donor site will be used and what happens if pigmentation is patchy.

Skin care, sun protection and camouflage

Depigmented skin burns easily because it lacks melanin protection. Broad-spectrum sunscreen, shade and protective clothing reduce burns and contrast from tanning of surrounding skin. Sunscreen does not restore colour but supports treatment and safer daily life.

  • Use a gentle cleanser and moisturiser if skin is dry or sensitive.
  • Avoid deliberate tanning and unregulated UV lamps.
  • Do not apply strong steroids, acids or herbal dyes without diagnosis.
  • Self-tanner and colour-correcting camouflage can provide immediate, washable or gradual coverage.
  • Photograph changing areas in consistent light rather than repeatedly rubbing or testing them.

Micropigmentation may be considered for selected stable areas, but colour matching, allergy, infection and future disease spread must be discussed. Tattooing active vitiligo can trigger new patches after trauma.

Children, pregnancy and associated health

Vitiligo treatment for children must account for age, body surface area, school routine and the emotional effect of visible patches. Potent medicines and phototherapy require specialist supervision. During pregnancy or breastfeeding, review every topical, tablet and light-based plan rather than assuming โ€œnaturalโ€ products are safer.

Vitiligo can occur alongside autoimmune thyroid disease and other autoimmune conditions. Testing is guided by symptoms, examination and personal or family history; indiscriminate panels are not useful for everyone. Rapid spread, hair turning white within patches or major distress deserves a focused review.

Mental wellbeing is part of treatment

The medical severity of a small facial patch may not reflect its social impact. Ask about confidence, work, school, relationships and unwanted comments. Support groups, counselling and practical camouflage can be as meaningful as repigmentation. Treatment decisions should belong to the person with vitiligo, not to pressure from others to hide natural colour variation.

Depigmentation is a specialised, uncommon choice

For extensive vitiligo, some adults ask about removing remaining natural pigment to create a more uniform appearance. Depigmentation is generally permanent, can take a long time and creates lifelong sun sensitivity. Uneven response, irritation and later pigment islands are possible. It is not skin lightening for cosmetic preference and requires specialist counselling about identity, reversibility and practical photoprotection before any prescription is considered.

Preparation, monitoring and cost

A candidate for vitiligo treatment needs a confirmed diagnosis and a goal: stabilisation, repigmentation, camouflage or a combination. Bring previous photographs and a list of medicines. Discuss patch location, duration, recent spread, pregnancy plans, immune conditions and ability to attend repeated visits.

Vitiligo treatment cost varies widely. A cream may involve monitoring and refills; phototherapy adds repeated travel and session fees; surgery adds donor-site care. Compare the full course rather than one appointment. The best treatment for vitiligo is the safest realistic plan for the pattern, activity and body siteโ€”not the method promising the fastest universal cure.

Vitiligo treatment review checkpoint

Vitiligo treatment reviewNext decision
Patches stable and repigmentingContinue the prescribed course and photograph progress
New patches, burning or no expected responseReassess diagnosis, activity, adherence and treatment fit

Find your starting point

Explore related topics

Explore treatment guides and prepare your questions for a consultation.

Vitiligo Treatment: FAQs

Answers to common questions about Vitiligo Treatment.

There is no guaranteed permanent cure, but treatment can stabilise disease and restore colour in some areas.
The best option depends on activity, pattern, body site, age, health and how much skin is affected.
Visible repigmentation usually takes months, and maintenance may be needed after a good response.
No. Face and neck often respond better than fingers, toes and areas with white hair.
No. Eligibility, affected surface area, age, warnings and local regulatory approval require prescriber review.
Yes. Treatment response and disease activity are different, and new patches can develop later.
No. Vitiligo cannot spread from one person to another through contact.
Selected stable patches may be considered for grafting or cellular procedures after specialist assessment.
Testing is individualised according to symptoms, examination and personal or family autoimmune history.
Seek diagnosis when a patch is new, spreading, itchy, scaly, follows chemical exposure or is otherwise uncertain.